Anthony J. Montagnolo, Chief Operating Officer and Executive Vice President, ECRI Institute
New healthcare technologies continue to emerge and diffuse rapidly throughout our healthcare systems. While the ongoing advances in technology often provide amazing new opportunities to improve health, this increasing diffusion of technology is often cited as a major driver of increasing cost. With this rapid pace of technological change, healthcare providers must find a way to better predict which technology developments will truly have an impact from both a clinical and financial perspective. With more technology choices to be made on one hand, and an increasing pressure to control costs on the other hand, the need for a better model of technology decision-making has become essential to every healthcare provider. To be successful in the future, every healthcare provider must have a more rational process for monitoring, predicting, and assessing emerging health technologies.
As a pioneer and leader in technology assessment and procurement, ECRI has developed effective strategies that demystify the technology decision-making process and provide a better clinical and economic return on an institution’s healthcare technology investment. These strategies are used by hundreds of healthcare providers worldwide to assess new and emerging technologies, to prioritize appropriately among competing technology choices, and to acquire technologies in the most cost-effective manner.